Biomatter Designs's Product Videos
ESPs containing Biomatter Designs
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Companies in this market use machine learning, physics-based simulations and molecular dynamics to discover and design proteins based on their folding patterns. These companies use state-of-the-art machine learning algorithms to determine previously undefined protein structures and interactions.
Compete with Biomatter Designs?
Ensure that your company and products are accurately represented on our platform.
Biomatter Designs's Products & Differentiators
Generative protein design platform
Biomatter Designs has pioneered the technology for AI-driven generative protein design. The generative approach allows us to navigate immense protein space effectively and construct useful proteins towards desired value creating results right from the first atom. The platform is based on generative AI which the company has developed from the ground up for protein science. It is widely applicable and tested with different types of proteins and engineering goals, including rapid improvement of enzyme activity, stability and specificity, and effective design of specific protein binders for therapeutic and diagnostic applications. The platform can swiftly generate functional proteins vastly different from natural counterparts and unique in properties, while ensuring minimal experimental burden due to high accuracy of designs.
Research containing Biomatter Designs
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Biomatter Designs in 1 CB Insights research brief, most recently on Nov 17, 2022.
Expert Collections containing Biomatter Designs
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Biomatter Designs is included in 3 Expert Collections, including Artificial Intelligence.
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Drug Discovery Tech Market Map
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Startups recreating how healthcare is delivered
Latest Biomatter Designs News
Jan 18, 2021
Details Details Share This Cobalt has advised Practica Capital on its investment in Lithuanian start-up Biomatter Designs — part of the latter's EUR 500,000 investment round. Biomatter Designs is a developer of a machine-learning powered platform for computational protein design. According to Cobalt, 70V and several angel investors participated in the round as well. The firm reported that the funds raised by Biomatter Designs will enable to to further drive its artificial intelligence platform to develop computational methods for designing new protein molecules. Cobalt did not reply to an inquiry about the deal.
Biomatter Designs Web Traffic
Biomatter Designs Rank
Biomatter Designs Frequently Asked Questions (FAQ)
When was Biomatter Designs founded?
Biomatter Designs was founded in 2018.
Where is Biomatter Designs's headquarters?
Biomatter Designs's headquarters is located at Zirmunu st. 139A, Vilnius.
What is Biomatter Designs's latest funding round?
Biomatter Designs's latest funding round is Seed VC.
How much did Biomatter Designs raise?
Biomatter Designs raised a total of $610K.
Who are the investors of Biomatter Designs?
Investors of Biomatter Designs include Practica Capital and 70V.
Who are Biomatter Designs's competitors?
Competitors of Biomatter Designs include LabGenius and 3 more.
What products does Biomatter Designs offer?
Biomatter Designs's products include Generative protein design platform.
Compare Biomatter Designs to Competitors
Cradle operates as a biotechnology company. It uses artificial intelligence (AI) assisted design tools to predict the 3D structure of a protein, generate new sequences with thermostability, optimize codons, and more. It serves biologists. The company was founded in 2021 and is based in Amsterdam, Netherlands.
Allozymes leverages microfluidics – or the study of the behavior of fluids – to build a fast and affordable enzyme development platform.
InstaDeep offers a host of AI solutions, ranging from optimized pattern recognition and GPU-accelerated insights to self-learning decision making systems.
Viridos is dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges. The company's main research and business programs are focused on the following major bioenergy areas: designing advanced biofuels with superior properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value-added products directly from sunlight and carbon dioxide; developing new biological solutions to increase production and/or recovery rates of subsurface hydrocarbons and developing high-yielding, more disease resistant and economic feedstocks. It was founded in 2005 and is based in La Jolla, California.
Cyrus Biotechnology offers advanced software tools for protein modeling and engineering to customers in Biotech, Pharma, Consumer Products, Chemicals, and Synthetic Biology. It is based in Seattle, Washington.
Erbi Biosystems is developing systems to automate the study of microorganisms for basic research and bioprocess characterization and optimization. Through microfluidics and integration, large scale bioreactors can be miniaturized to the milliliter scale, enabling greatly reduced volumes in addition to automated control.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.